News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
742,813 Results
Type
Article (50174)
Company Profile (280)
Press Release (692358)
Multimedia
Podcasts (74)
Webinars (14)
Section
Business (212457)
Career Advice (2103)
Deals (36573)
Drug Delivery (104)
Drug Development (83743)
Employer Resources (173)
FDA (17057)
Job Trends (15750)
News (359684)
Policy (34777)
Tag
Academia (2784)
Accelerated approval (10)
Adcomms (26)
Allergies (98)
Alliances (51757)
ALS (113)
Alzheimer's disease (1507)
Antibody-drug conjugate (ADC) (157)
Approvals (17053)
Artificial intelligence (335)
Autoimmune disease (29)
Automation (19)
Bankruptcy (374)
Best Places to Work (12096)
BIOSECURE Act (19)
Biosimilars (123)
Biotechnology (190)
Bladder cancer (95)
Brain cancer (36)
Breast cancer (378)
Cancer (2941)
Cardiovascular disease (226)
Career advice (1767)
Career pathing (31)
CAR-T (189)
CDC (34)
Cell therapy (510)
Cervical cancer (24)
Clinical research (68812)
Collaboration (1048)
Company closure (3)
Compensation (690)
Complete response letters (25)
COVID-19 (2753)
CRISPR (58)
C-suite (343)
Cystic fibrosis (113)
Data (3040)
Decentralized trials (2)
Denatured (30)
Depression (68)
Diabetes (357)
Diagnostics (6640)
Digital health (24)
Diversity (10)
Diversity, equity & inclusion (46)
Drug discovery (140)
Drug pricing (130)
Drug shortages (31)
Duchenne muscular dystrophy (128)
Earnings (89627)
Editorial (43)
Employer branding (21)
Employer resources (149)
Events (118816)
Executive appointments (869)
FDA (18770)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (960)
Gene editing (134)
Generative AI (28)
Gene therapy (384)
GLP-1 (839)
Government (4780)
Grass and pollen (4)
Guidances (181)
Healthcare (19930)
HIV (42)
Huntington's disease (30)
IgA nephropathy (39)
Immunology and inflammation (152)
Immuno-oncology (9)
Indications (40)
Infectious disease (2936)
Inflammatory bowel disease (154)
Inflation Reduction Act (10)
Influenza (66)
Intellectual property (120)
Interviews (320)
IPO (16959)
IRA (45)
Job creations (4052)
Job search strategy (1504)
Kidney cancer (13)
Labor market (52)
Layoffs (512)
Leadership (19)
Legal (8488)
Liver cancer (82)
Longevity (12)
Lung cancer (413)
Lymphoma (211)
Machine learning (11)
Management (58)
Manufacturing (398)
MASH (93)
Medical device (14478)
Medtech (14483)
Mergers & acquisitions (20342)
Metabolic disorders (891)
Multiple sclerosis (99)
NASH (16)
Neurodegenerative disease (124)
Neuropsychiatric disorders (36)
Neuroscience (2214)
NextGen: Class of 2025 (6920)
Non-profit (4749)
Now hiring (47)
Obesity (452)
Opinion (231)
Ovarian cancer (102)
Pain (111)
Pancreatic cancer (122)
Parkinson's disease (192)
Partnered (22)
Patents (302)
Patient recruitment (169)
Peanut (52)
People (60568)
Pharmaceutical (68)
Pharmacy benefit managers (22)
Phase I (21414)
Phase II (30237)
Phase III (22577)
Pipeline (1653)
Policy (206)
Postmarket research (2741)
Preclinical (9159)
Press Release (67)
Prostate cancer (145)
Psychedelics (39)
Radiopharmaceuticals (263)
Rare diseases (475)
Real estate (6314)
Recruiting (66)
Regulatory (24084)
Reports (50)
Research institute (2488)
Resumes & cover letters (360)
Rett syndrome (9)
RNA editing (8)
RSV (52)
Schizophrenia (93)
Series A (158)
Series B (112)
Service/supplier (13)
Sickle cell disease (62)
Special edition (18)
Spinal muscular atrophy (153)
Sponsored (34)
Startups (3843)
State (2)
Stomach cancer (15)
Supply chain (79)
Tariffs (59)
The Weekly (42)
Vaccines (825)
Venture capital (55)
Weight loss (286)
Women's health (50)
Worklife (16)
Date
Today (93)
Last 7 days (374)
Last 30 days (1869)
Last 365 days (31912)
2025 (17227)
2024 (36109)
2023 (41146)
2022 (52384)
2021 (57101)
2020 (55911)
2019 (48799)
2018 (36940)
2017 (33748)
2016 (33566)
2015 (39611)
2014 (33326)
2013 (28558)
2012 (30847)
2011 (31551)
2010 (29925)
Location
Africa (796)
Alabama (63)
Alaska (7)
Arizona (252)
Arkansas (14)
Asia (41412)
Australia (6805)
California (7529)
Canada (2377)
China (697)
Colorado (332)
Connecticut (336)
Delaware (197)
Europe (89790)
Florida (1131)
Georgia (257)
Hawaii (1)
Idaho (63)
Illinois (685)
India (28)
Indiana (368)
Iowa (16)
Japan (234)
Kansas (112)
Kentucky (30)
Louisiana (15)
Maine (64)
Maryland (1069)
Massachusetts (5652)
Michigan (254)
Minnesota (468)
Mississippi (3)
Missouri (92)
Montana (28)
Nebraska (25)
Nevada (83)
New Hampshire (71)
New Jersey (2120)
New Mexico (29)
New York (2114)
North Carolina (1153)
North Dakota (8)
Northern California (3304)
Ohio (238)
Oklahoma (16)
Oregon (35)
Pennsylvania (1625)
Puerto Rico (17)
Rhode Island (38)
South America (1187)
South Carolina (36)
South Dakota (1)
Southern California (2816)
Tennessee (128)
Texas (1146)
United States (28205)
Utah (224)
Virginia (192)
Washington D.C. (76)
Washington State (656)
West Virginia (4)
Wisconsin (71)
742,813 Results for "sunrise medical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BioVie to Present Overview of Phase 2 SUNRISE-PD Trial at the Advanced Therapeutics in Movement & Related Disorders® Congress
June 25, 2025
·
8 min read
Press Releases
BioVie Highlights Patient-Centric Design of SUNRISE-PD Trial at Advanced Therapeutics in Movement & Related Disorders® Congress (ATMRD)
June 26, 2025
·
10 min read
Press Releases
BioVie Initiates SUNRISE-PD Clinical Trial Assessing Bezisterim in Early Parkinson’s Disease with First Patient Enrolled
April 16, 2025
·
10 min read
Press Releases
BioVie to Present Rationale and Design of Phase 2 SUNRISE-PD Clinical Trial at the 30th World Congress on Parkinson’s Disease and Related Disorders (IAPRD 2025)
May 7, 2025
·
8 min read
Press Releases
Spectral Medical Inc. Announces Filing of Base Shelf Prospectus
July 7, 2025
·
4 min read
Press Releases
Piccolo Medical, Inc. Receives FDA Clearance for 2nd Generation SmartPICC® technology
July 16, 2025
·
3 min read
Press Releases
Spectral Medical Inc. Announces Results of Annual Meeting of Shareholders
June 9, 2025
·
3 min read
Press Releases
Inspire Medical Systems, Inc. to Report Second Quarter 2025 Financial Results on August 4, 2025
July 8, 2025
·
1 min read
BioVie Presents Protocol Design of Upcoming SUNRISE-PD Phase 2 Trial of Bezisterim in Patients with Early Parkinson’s Disease at ATMRD 2024
BioVie Inc. today announced data from two presentations at the Advanced Therapeutics in Movement and Related Disorders Congress® (ATMRD Congress) held June 21-25, 2024 in Washington, D.C.
June 25, 2024
·
10 min read
Press Releases
Aethlon Medical, Inc. Announces Positive Data Safety Monitoring Board Review and Recommendation to Advance to Next Clinical Trial Cohort
July 16, 2025
·
5 min read
1 of 74,282
Next
